Medtronic today announced it has entered into an exclusive U.S. distribution agreement with Japan-based Future Medical Design Co (FMD) to sell specialty and workhorse peripheral guidewires. This agreement includes the first 400cm, 0.018″ peripheral guidewire available in the U.S., expanding the Medtronic portfolio for transradial access for the treatment of peripheral arterial disease (PAD).
Medtronic shares that it is the sole distributor of 10 new F-14 and F-18 peripheral stainless steel guidewires, available in 300cm and 400cm lengths. According to the company, the 0.018” 400cm wire, along with the 200cm working length IN.PACT 018 drug-coated balloon and Pacific Plus percutaneous transluminal angioplasty (PTA) catheter, provides physicians with a comprehensive suite of tools needed to reach lesions from a transradial approach.
Medtronic details that the FMD guidewires are engineered for crossability, trackability, and tip retention, allowing for the treatment of complex cases.
